Were filing lawsuits against these drugmakers for failing to properly warn people of the risk of gastroparesis, ileus and intestinal blockages
Krainz T, Gaschler MM, Lim C, Sacher JR, Stockwell BR, Wipf P
Lilly said the latest trial also showed orforglipron improved heart-risk markers, lowering cholesterol, triglycerides and blood pressure across all doses
Mention any medications you take (prescription and over-the-counter) and if youve been diagnosed with a specific condition
The Promise of Injectable GLP-1 Receptor Agonists: Reshaping Strategies in Obesity Treatment The escalating prevalence of obesity presents a pressing public health challenge
PubMed laboratory research record [PMID: 3930869] PubMed record related to this compound for laboratory literature review